CLINICAL_TRIALS
trial_result
· 2012-07-02
Clinical Trial Update: Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia [Phase 2]
Summary
Phase 2 clinical trial evaluating interleukin-2 in relapsed or refractory acute myeloid leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Leukemia | Phase 2 | Status: COMPLETED